150P Phase I/IIa trial of CD200R1 inhibitor 23ME-00610: Exploratory analyses of tissue-based and genetic biomarkers.

Saved in:
Bibliographic Details
Title: 150P Phase I/IIa trial of CD200R1 inhibitor 23ME-00610: Exploratory analyses of tissue-based and genetic biomarkers.
Authors: Razak, A.R. Abdul1 (AUTHOR), Naing, A.2 (AUTHOR), Diep, A.N.3 (AUTHOR), Hwang, C.C.3 (AUTHOR), Reisetter, A.C.3 (AUTHOR), Fuller, Z.L.3 (AUTHOR), Hom, C.3 (AUTHOR), Glatt, D.M.3 (AUTHOR), Schmidt, M.3 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS274-S275. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2024.08.158